Simple blood tests could predict immunotherapy effectiveness

Dr George Laliotis and his team predict the response of head and neck squamous cell carcinoma (HNSCC) patients to immunotherapy using precision-medicine techniques.

Despite the extensive use of immunotherapy in patients suffering from head and neck squamous cell carcinoma, this therapy has significant limitations. Not everyone responds to treatment and current therapies can have serious adverse side effects. When working at the Johns Hopkins School of Medicine, Sidney Kimmel Comprehensive Cancer Center, USA, Dr George Laliotis and his team discovered that biochemical factors, measured […]

Read More… from Simple blood tests could predict immunotherapy effectiveness

Fluorescent imaging sheds new light on apoptosis

Fluorescent imaging sheds new light on apoptosis

Researchers at the Avera Cancer Institute are using state-of-the-art fluorescent imaging to shed new light on the physical and biochemical processes behind apoptosis – also known as ‘programmed cell death’. The novel, cost-effective and user-friendly method uses three fluorescent stains, enabling the real-time, structure-function based identification of apoptosis in live, apoptotic tumour cells. This unique protocol developed by Dr Nandini […]

Read More… from Fluorescent imaging sheds new light on apoptosis